About The Study: Bariatric metabolic surgery was associated with greater reduced mortality compared with first-generation glucagon-like peptide-1 receptor agonists (GLP-1RAs) among individuals with a diabetes duration of 10 years or less, mediated via greater weight loss in this cohort study. No differences in the risk for mortality were observed between the treatment modalities among individuals with a longer duration of diabetes, nor in the occurrence of nonfatal major adverse cardiovascular events among all patients.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.